Xin Hu

15PUBLICATIONS
29CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 08, 2026
Complex I protein NDUFB9 is a metabolic vulnerability in triple negative breast cancer brain metastases.

|Apr 13, 2026
Integrative multi-omic analysis identified ERBB2 mutations and senescence-driven immune suppression as dual therapeutic targets in LAR triple-negative breast cancer.

Yaxin Zhao, Han Wang, Ying Wang

|Aug 11, 2025
CRISPR screening reveals that RNA helicase DDX41 triggers ribosome biogenesis and cancer progression through R-loop-mediated RPL/RPS transcription.

Hongquan Li, Yifei He, Jiawen Jiang

|Jul 31, 2025
Dalpiciclib combined with pyrotinib and endocrine therapy in women with ER-positive, HER2-positive advanced breast cancer: A prospective, multicenter, single-arm, phase 2 trial.

Jian Zhang, Yanchun Meng, Biyun Wang

|Jul 18, 2025
Retrospective insights: clinical characteristics and survival in 403 ILC cases from China.

Javaria Nasir, Boyue Han, Xin Hu

|Sep 20, 2024
Multiomics and single-cell sequencings reveal the specific biological characteristics of low Ki-67 triple-negative breast cancer.

Boyue Han, Xiangchen Han, Hong Luo

Pageof 3

Frequent Collaborators

3 joint publications

Zhi-Ming Shao

3 joint publications

Hong Ling

2 joint publications

Yu-Chen Pei

2 joint publications

Boyue Han